1. Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation
   Víctor Amado et al, 2021, Cancers CrossRef
2. Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation
   Hyeo Seong Hwang et al, 2022, Gut and Liver CrossRef
3. Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
   Stéphanie Gonvers et al, 2022, Frontiers in Oncology CrossRef
4. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal
   María Lola Espejo-Cruz et al, 2021, International Journal of Molecular Sciences CrossRef
5. Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds?
   Tsuyoshi Shimamura et al, 2022, Cancers CrossRef
6. Neoadjuvant Therapy for Hepatocellular Carcinoma
   Zongyi Yin et al, 2022, Journal of Hepatocellular Carcinoma CrossRef
7. European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation
   Marina Berenguer et al, 2023, Transplant International CrossRef
8. EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma
   Lorenz Kocheise et al, 2023, Scientific Reports CrossRef
9. Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
   Filippo Pelizzaro et al, 2021, Cancers CrossRef